Total Payments
$14,061
2023 Payments
$151.69
Companies
10
Transactions
16
Medicare Patients
2,165
Medicare Billing
$254,367
Payment Breakdown by Category
Consulting$9,829 (69.9%)
Other$3,065 (21.8%)
Food & Beverage$678.00 (4.8%)
Education$301.23 (2.1%)
Travel$187.35 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $9,829 | 4 | 69.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,065 | 1 | 21.8% |
| Food and Beverage | $678.00 | 9 | 4.8% |
| Education | $301.23 | 1 | 2.1% |
| Travel and Lodging | $187.35 | 1 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $8,149 | 3 | $0 (2020) |
| Philips Electronics North America Corporation | $3,252 | 2 | $0 (2017) |
| Genentech, Inc. | $1,680 | 1 | $0 (2020) |
| W. L. Gore & Associates, Inc. | $400.26 | 2 | $0 (2020) |
| JAZZ PHARMACEUTICALS INC. | $209.74 | 3 | $0 (2023) |
| Inspire Medical Systems, Inc. | $129.65 | 1 | $0 (2017) |
| Advanced Respiratory, Inc | $116.27 | 1 | $0 (2018) |
| GlaxoSmithKline, LLC. | $53.06 | 1 | $0 (2020) |
| Breas Medical, Inc. | $49.77 | 1 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $20.48 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $151.69 | 3 | JAZZ PHARMACEUTICALS INC. ($101.92) |
| 2022 | $20.48 | 1 | AstraZeneca Pharmaceuticals LP ($20.48) |
| 2020 | $6,787 | 5 | GENZYME CORPORATION ($4,753) |
| 2019 | $3,495 | 2 | GENZYME CORPORATION ($3,396) |
| 2018 | $224.09 | 2 | Advanced Respiratory, Inc ($116.27) |
| 2017 | $3,382 | 3 | Philips Electronics North America Corporation ($3,252) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/06/2023 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $70.67 | General |
| Category: NEUROLOGY | ||||||
| 06/04/2023 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $31.25 | General |
| Category: NEUROLOGY | ||||||
| 05/19/2023 | Breas Medical, Inc. | Vivo 45 LS (Device) | Food and Beverage | In-kind items and services | $49.77 | General |
| Category: Respiratory | ||||||
| 03/12/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: Respiratory | ||||||
| 09/22/2020 | Genentech, Inc. | EVRYSDI (Drug) | Consulting Fee | Cash or cash equivalent | $1,680.00 | General |
| Category: NEUROLOGY | ||||||
| 07/27/2020 | GENZYME CORPORATION | LUMIZYME (Biological) | Consulting Fee | Cash or cash equivalent | $1,358.00 | General |
| Category: Genetic Disease | ||||||
| 06/03/2020 | W. L. Gore & Associates, Inc. | BIO-A Tissue Reinforcement (Device) | Education | In-kind items and services | $301.23 | General |
| Category: Devices | ||||||
| 04/24/2020 | GENZYME CORPORATION | LUMIZYME (Biological) | Consulting Fee | Cash or cash equivalent | $3,395.00 | General |
| Category: Genetic Disease | ||||||
| 01/17/2020 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $53.06 | General |
| 10/21/2019 | GENZYME CORPORATION | LUMIZYME (Drug) | Consulting Fee | Cash or cash equivalent | $3,396.00 | General |
| Category: RARE DISEASE GENETICS | ||||||
| 08/01/2019 | W. L. Gore & Associates, Inc. | SEAMGUARD Bioabsorbable Staple Line Reinforcement (Device) | Food and Beverage | In-kind items and services | $99.03 | General |
| Category: Devices | ||||||
| 10/08/2018 | Advanced Respiratory, Inc | Vest 205 Metaneb System (Device) | Food and Beverage | In-kind items and services | $116.27 | General |
| Category: Airway Clearance Device | ||||||
| 06/03/2018 | Jazz Pharmaceuticals Inc. | Xyrem (Drug) | Food and Beverage | In-kind items and services | $107.82 | General |
| Category: Neurology | ||||||
| 04/20/2017 | Philips Electronics North America Corporation | DreamStat Cpap Pro (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,065.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/20/2017 | Philips Electronics North America Corporation | DreamStat Cpap Pro (Device) | Travel and Lodging | Cash or cash equivalent | $187.35 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/27/2017 | Inspire Medical Systems, Inc. | Inspire Upper Airway Stimulation System (Device) | Food and Beverage | Cash or cash equivalent | $129.65 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 723 | 900 | $540,996 | $75,312 |
| 2022 | 15 | 958 | 1,255 | $745,303 | $107,209 |
| 2021 | 8 | 293 | 428 | $308,708 | $50,204 |
| 2020 | 3 | 191 | 245 | $104,810 | $21,642 |
Total Patients
2,165
Total Services
2,828
Medicare Billing
$254,367
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 74 | 151 | $279,803 | $28,610 | 10.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 58 | 74 | $44,563 | $9,493 | 21.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 50 | 67 | $52,497 | $7,410 | 14.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 26 | 58 | $21,353 | $5,962 | 27.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 31 | 31 | $16,147 | $4,718 | 29.2% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 20 | 48 | $37,104 | $4,562 | 12.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 29 | 29 | $20,162 | $4,200 | 20.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 13 | 13 | $9,841 | $2,079 | 21.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 24 | 26 | $17,626 | $1,962 | 11.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $9,184 | $1,726 | 18.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 13 | 13 | $6,940 | $1,084 | 15.6% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 80 | 81 | $4,896 | $604.96 | 12.4% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 52 | 52 | $3,968 | $515.85 | 13.0% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 57 | 58 | $3,602 | $496.80 | 13.8% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2023 | 12 | 14 | $4,438 | $477.23 | 10.8% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 47 | 47 | $2,162 | $379.76 | 17.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 37 | 37 | $1,887 | $346.69 | 18.4% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 34 | 34 | $1,734 | $254.32 | 14.7% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 30 | 31 | $1,797 | $220.80 | 12.3% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 19 | 19 | $1,292 | $208.05 | 16.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 89 | 238 | $441,014 | $45,469 | 10.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 74 | 158 | $58,144 | $14,802 | 25.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 48 | 49 | $33,529 | $8,947 | 26.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 53 | 70 | $41,048 | $8,165 | 19.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 36 | 47 | $38,880 | $5,374 | 13.8% |
About Dr. Michelle Cao, DO
Dr. Michelle Cao, DO is a Critical Care Medicine healthcare provider based in Stanford, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1386791762.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michelle Cao, DO has received a total of $14,061 in payments from pharmaceutical and medical device companies, with $151.69 received in 2023. These payments were reported across 16 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($9,829).
As a Medicare-enrolled provider, Cao has provided services to 2,165 Medicare beneficiaries, totaling 2,828 services with total Medicare billing of $254,367. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Sleep Medicine, Internal Medicine
- Location Stanford, CA
- Active Since 01/05/2007
- Last Updated 12/12/2024
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1386791762
Products in Payments
- LUMIZYME (Biological) $4,753
- LUMIZYME (Drug) $3,396
- DreamStat Cpap Pro (Device) $3,252
- EVRYSDI (Drug) $1,680
- BIO-A Tissue Reinforcement (Device) $301.23
- Inspire Upper Airway Stimulation System (Device) $129.65
- Vest 205 Metaneb System (Device) $116.27
- Xyrem (Drug) $107.82
- XYWAV (Drug) $101.92
- SEAMGUARD Bioabsorbable Staple Line Reinforcement (Device) $99.03
- Vivo 45 LS (Device) $49.77
- FASENRA (Biological) $20.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Stanford
Deborah Levine, Md, MD
Critical Care Medicine — Payments: $171,271
Critical Care Medicine $171,271
Roger Mecca, M.d, M.D
Critical Care Medicine — Payments: $89,820
Critical Care Medicine $89,820
Arthur Sung, Md, MD
Critical Care Medicine — Payments: $49,571
Critical Care Medicine $49,571
Claudia Sotillo, M.d, M.D
Critical Care Medicine — Payments: $25,016
Critical Care Medicine $25,016
Rishi Raj, M.d, M.D
Critical Care Medicine — Payments: $16,217
Critical Care Medicine $16,217
Dr. Stephen Ruoss, M.d, M.D
Critical Care Medicine — Payments: $13,505
Critical Care Medicine $13,505